Key Takeaways
- Spain’s Supreme Court ruling on April 23, 2026, has serious implications for the hemp industry, particularly regarding THC levels in products.
- The court ruled that total THC across a shipment, not just per-unit concentration, defines legal compliance, exposing products to criminal risks.
- Despite the historic 0.2% to 0.3% THC threshold, retail legality remains uncertain, leading to ongoing legal challenges for hemp retailers in Spain.
- Some prosecutors already cite this ruling against other CBD and hemp businesses, causing concern within the industry.
- Operators and attorneys are advocating for clearer regulations to help navigate the post-ruling landscape and reduce legal risks.
For a while, Spain’s hemp industry worked off a simple assumption: stay under roughly 0.2% to 0.3% THC and your flower products were safe to sell. That assumption just took a serious hit.
On April 23, 2026, Spain’s Supreme Court handed down Judgment 301/2026, reinstating a criminal conviction against Rafael Fernández de Noreña, former operator of Barcelona-based Sensitive CBD. The business closed before the ruling landed, but the legal fallout didn’t end there. Industry attorneys now say prosecutors are citing the decision against other hemp-flower retailers, and trade groups across Spain are scrambling to respond.
This isn’t a story about one shuttered shop. It’s a story about how a single judgment can reshape risk for an entire industry, and why Spain’s agricultural THC threshold never actually guaranteed retail legality in the first place.
What Did Spain’s Supreme Court Rule in the Sensitive CBD Case?
The case traces back to December 2020, when customs officials intercepted two packages from Sensitive CBD headed to a distributor in France. The shipment included cosmetics, infusions, cigarettes, hemp cigars, and loose plant material. Lab testing found THC concentrations between 0.3% and 0.7% in several of the plant-based samples.
A Barcelona criminal court convicted Fernández de Noreña in January 2023, handing down one year and two months in prison plus an €8,000 fine. The Barcelona Provincial Court overturned that conviction on appeal in May 2023, finding the psychoactive potential hadn’t been sufficiently proven.
The Public Prosecutor’s Office pushed back, and the case landed before the Supreme Court. On April 23, 2026, the court sided with prosecutors and reinstated the original sentence. Crucially, the ruling drew a line between the plant-based products, which it treated as criminally relevant, and the infusions and cosmetics in the same shipment, which it excluded from that classification because they tested as synthetic CBD with no illicit material detected.
By the time the ruling came down, Sensitive CBD had already stopped operating. Fernández de Noreña told journalists at El Planteo he doesn’t expect to serve prison time, since he has no prior record, but the €8,000 fine and ongoing legal costs remain a real burden.
Why Does Total Shipment THC Matter More Than Percentage?
Here’s where the ruling gets technical, and where it starts to bite. The court didn’t just look at THC concentration per gram. It looked at the total net THC across the entire shipment, then compared that figure against Spain’s judicially recognized minimum psychoactive dose of 10 milligrams.
That distinction matters enormously in practice. A gram of plant material at 0.3% THC contains roughly 3 milligrams of THC. A single gram poses little concern under that threshold. But scale that up to 100 grams, a perfectly ordinary wholesale quantity, and the total climbs to 300 milligrams, thirty times over the court’s reference point.
The concentration never changed. Only the quantity did. That’s the trap: a product can be compliant on a per-unit basis and still become criminally exposed the moment it’s packaged for commercial distribution rather than individual sale.
Fernández de Noreña has pushed back on this logic directly, pointing out that no single consumer buys and uses an entire wholesale shipment at once. The court’s position, though, is that it’s evaluating cannabis destined to circulate among multiple third parties, not a single dose consumed by one person. That framing treats the shipment as the relevant unit of analysis rather than the individual package.
The Supreme Court also dismissed the lower appellate court’s reliance on a “psychoactivity index,” a ratio comparing THC, CBD, and CBN levels borrowed from a United Nations technical manual. The court found that index useful as a lab reference but insufficient on its own to determine criminal typicity. In plain terms: a favorable ratio doesn’t automatically clear a product of risk.
Was Spain’s 0.2% THC Threshold Ever a Legal Safe Harbor?
Not really, and this is the part of the story that predates the Sensitive CBD ruling entirely. The 0.2% and 0.3% THC figures that have circulated in Spain’s hemp sector for years originate from agricultural rules governing hemp cultivation, tied to the EU’s Common Agricultural Policy framework for certified seed varieties. They were never designed to answer the question of whether a finished retail product can be sold legally.
Albert Mayol, founder of Barcelona-based CBD Side, has been direct about this gap he told El Planteo. His company sources products with invoices and lab analysis from within the EU, consults legal counsel, and reviews labeling carefully. None of that eliminates the risk that a court applies a different standard entirely, as happened with Sensitive CBD.
The industry adopted the 0.2% to 0.3% figures as a working reference in the absence of clearer retail-specific rules, not because any regulation declared that threshold a guarantee of legality. The Supreme Court’s shipment-wide THC analysis exposes just how shaky that assumption always was.
Is the Ruling Already Being Used Against Other Hemp Retailers?
According to Isidre Carballido Enrich, founder of Cannactiva, attorneys in the space report that some prosecutors are already citing STS 301/2026 against other flower retailers. No consolidated count of these cases exists yet. Industry associations are still gathering examples as they surface.
That uncertainty is itself part of the problem. A Supreme Court ruling doesn’t automatically become binding precedent the way repeated, consistent rulings do. But as attorney Marta de Luxán Marco of De Luxán & Nieto Abogadas puts it, the decision “doesn’t create case law, but it carries enormous weight.” Her reasoning: most judges are reluctant to rule against something the Supreme Court has already decided, regardless of its formal precedential status.
CBD Side’s own analysis of the ruling, published shortly after it came down, makes a similar point: the judgment resolves one specific criminal case. It isn’t a law, a regulation, or a government policy on the CBD market. Its influence spreads through citation, not through binding force, and that’s exactly what appears to be happening.
What Has the Ruling Cost Businesses So Far?
For Fernández de Noreña, the financial toll has been steep. He estimates Sensitive CBD lost roughly €200,000 over eight years, a figure built from seized inventory, replacement shipments sent to preserve client relationships, and accumulated legal fees. That estimate covers the years leading up to the April 2026 ruling, not the ruling itself.
By the time the Supreme Court reinstated his conviction, the business had already closed and he had moved abroad for other work. He initially didn’t believe he had the resources to continue fighting the case. What changed his mind was support from competitors.
Other CBD operators began reaching out, offering to help fund his defense. Attorney Héctor Brotons, who specializes in cannabis-related cases, was among the first to call. A broader coalition eventually formed, pooling funds to retain a legal team experienced in constitutional litigation. Many of the businesses contributing to that fund were still actively selling the same category of products at the center of the case.
AECANI, the Spanish Association of Industrial Hemp, commissioned a legal analysis from a university professor specializing in EU law and constitutional guarantees. We designed this member-exclusive report to give defense attorneys a framework for raising European law arguments in future hemp-related prosecutions, extending its usefulness well beyond any single case.
Could Spain’s CBD Flower Cases Reach the European Court of Justice?
This question sits at the center of the industry’s long-term strategy. Spanish hemp operators and their attorneys are leaning heavily on EU law, particularly the 2020 Kanavape ruling from the Court of Justice of the European Union. This ruling determined that CBD legally produced in one member state is not a narcotic and falls under the EU’s free movement of goods protections. Restrictions require a justified public health rationale backed by scientific evidence, not abstract risk.
Spain’s Supreme Court acknowledged Kanavape in its reasoning but concluded it didn’t apply here, since the Sensitive CBD case involved plant material containing THC intended for consumption, not isolated cannabidiol. Attorneys representing the industry dispute that distinction and argue the same proportionality principles should extend to hemp flower legally produced elsewhere in the EU.
France offers a useful comparison point. In December 2022, France’s Conseil d’État struck down a blanket ban on selling hemp flowers and leaves from authorized varieties with up to 0.3% THC, finding no demonstrated health risk sufficient to justify an absolute prohibition. That ruling doesn’t bind Spanish courts, but it shows the same underlying legal questions can produce different outcomes.
For the Kanavape precedent or similar reasoning to directly shape future Spanish cases, a domestic court would need to refer a preliminary question to the CJEU, something defense teams can request but can’t compel. A separate route, a constitutional appeal before Spain’s Constitutional Court, remains available but carries strict admissibility requirements and doesn’t pause a sentence automatically. Whether either path opens up will depend on how the next wave of cases unfolds.
What Should Hemp Businesses in Spain Watch For Next?
CBD Side and Cannactiva both report no changes to their product catalogs since the ruling, and both continue operating with legal counsel in place. But operators and attorneys following this closely describe a climate that has shifted from cautious optimism to a guarded watch-and-wait posture.
AECANI is pushing for operator registries and clearer commercial standards, arguing that better traceability would help separate businesses meeting real compliance standards from those exploiting regulatory gaps, including unregulated synthetic cannabinoid products sometimes sold under the same “CBD shop” label.
Carballido Enrich has said he’d prefer a legislative fix over a judicial one, noting that “regulation by court ruling is never good; it always leaves gaps exposed.” That sentiment captures where much of the industry stands right now: hoping for clarity from lawmakers or Europe, while bracing for more prosecutions built on the same total-THC reasoning in the meantime.
For now, the practical takeaway for any business selling hemp flower or plant-based CBD products in Spain is this: per-unit THC compliance under 0.3% doesn’t settle the legal question anymore. Criminal analysts can now examine the volume of product moving through a shipment, how it’s packaged, and its intended use.
Frequently Asked Questions
Spain’s Supreme Court (Judgment 301/2026, April 23, 2026) upheld a criminal conviction against a Barcelona hemp retailer, setting a precedent that puts businesses selling cannabis flower or THC-containing products at legal risk — both domestically and across the EU.
The 0.3% THC legal limit applies to agricultural cultivation, not retail sales. A Supreme Court ruling determined that total THC across an entire shipment — not just per-unit concentration — is what matters legally. This means seemingly compliant products can still carry criminal risks when sold in commercial quantities.
Some prosecutors are using a recent ruling to target hemp-flower retailers, and trade associations are tracking these cases as they arise.
No Spanish court has yet referred the case to the CJEU, but industry attorneys argue that the ruling conflicts with the CJEU’s 2020 Kanavape decision. To formally test this conflict, a Spanish court would need to refer the case to the CJEU or escalate it through Spain’s Constitutional Court.
To stay compliant, cannabis businesses should maintain thorough lab testing and sourcing records, consult legal counsel experienced in cannabis law, avoid packaging that implies direct consumption, and monitor THC levels per shipment against Spain’s 10mg psychoactive threshold.
